Xiaofeng Zhou

754 total citations
24 papers, 475 citations indexed

About

Xiaofeng Zhou is a scholar working on Toxicology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Xiaofeng Zhou has authored 24 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Toxicology, 5 papers in Economics and Econometrics and 4 papers in Epidemiology. Recurrent topics in Xiaofeng Zhou's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Meta-analysis and systematic reviews (3 papers). Xiaofeng Zhou is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Meta-analysis and systematic reviews (3 papers). Xiaofeng Zhou collaborates with scholars based in United States, China and United Kingdom. Xiaofeng Zhou's co-authors include Manfred Hauben, Andrew Bate, Bing Cai, Rachel E. Sobel, Kui Huang, Hongbo Lin, Staci Abramsky, Siyan Zhan, Phillip Chappell and Robert L. Findling and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Journal of Materials Processing Technology and Vaccine.

In The Last Decade

Xiaofeng Zhou

23 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Zhou United States 13 153 67 64 61 58 24 475
Harry Seifert United States 15 195 1.3× 43 0.6× 122 1.9× 86 1.4× 46 0.8× 36 914
Alexandra Păcurariu Netherlands 12 184 1.2× 136 2.0× 60 0.9× 105 1.7× 38 0.7× 24 524
Marion Lepelley France 16 141 0.9× 42 0.6× 61 1.0× 91 1.5× 10 0.2× 42 574
Joseph M. Plasek United States 13 81 0.5× 21 0.3× 38 0.6× 47 0.8× 14 0.2× 42 544
Yonas Ghebremichael‐Weldeselassie United Kingdom 14 62 0.4× 32 0.5× 126 2.0× 24 0.4× 52 0.9× 28 618
Siti Maisharah Sheikh Ghadzi Malaysia 9 47 0.3× 47 0.7× 57 0.9× 26 0.4× 9 0.2× 46 526
Stella Stergiopoulos United States 12 69 0.5× 123 1.8× 19 0.3× 17 0.3× 41 0.7× 28 383
Georgy Genov Netherlands 9 199 1.3× 144 2.1× 13 0.2× 59 1.0× 30 0.5× 14 389
Rupa Makadia United States 7 26 0.2× 43 0.6× 62 1.0× 24 0.4× 31 0.5× 12 598
Lingling Li United States 12 56 0.4× 73 1.1× 50 0.8× 10 0.2× 255 4.4× 18 426

Countries citing papers authored by Xiaofeng Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Zhou more than expected).

Fields of papers citing papers by Xiaofeng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Zhou. The network helps show where Xiaofeng Zhou may publish in the future.

Co-authorship network of co-authors of Xiaofeng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Zhou. A scholar is included among the top collaborators of Xiaofeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Zhou. Xiaofeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gini, Rosa, Romin Pajouheshnia, Helga Gardarsdóttir, et al.. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety. 33(5). e5787–e5787. 3 indexed citations
2.
Hoffman, Sarah R., Kimberly Daniels, Ryan Seals, et al.. (2023). Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study. Menopause The Journal of The North American Menopause Society. 30(8). 824–830. 6 indexed citations
3.
4.
Curtis, Jeffrey R., Xiaofeng Zhou, David T. Rubin, et al.. (2021). Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study. The Journal of Rheumatology. 49(3). 320–329. 22 indexed citations
5.
Deuring, J. Jasper, et al.. (2021). Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?. Current Therapeutic Research. 95. 100639–100639. 1 indexed citations
7.
Findling, Robert L., Xiaofeng Zhou, Prethibha George, & Phillip Chappell. (2021). Diagnostic Trends and Prescription Patterns in Disruptive Mood Dysregulation Disorder and Bipolar Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 61(3). 434–445. 21 indexed citations
9.
Mo, Jingping, Charu Sabharwal, Elizabeth Begier, et al.. (2020). The incidence of stroke among selected patients undergoing elective posterior lumbar fusion: a retrospective cohort study. BMC Musculoskeletal Disorders. 21(1). 612–612. 3 indexed citations
10.
Hall, Gillian C., Stephan Lanes, Kaatje Bollaerts, et al.. (2020). Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence. Pharmacoepidemiology and Drug Safety. 29(11). 1450–1455. 15 indexed citations
11.
Zhou, Xiaofeng, Cynthia de Luise, Michael Gaffney, et al.. (2019). National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States. International Journal of Pediatric Otorhinolaryngology. 119. 96–102. 18 indexed citations
13.
Yang, Yu, Xiaofeng Zhou, Hongbo Lin, et al.. (2017). Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China. Drug Safety. 41(1). 125–137. 36 indexed citations
14.
Asomaning, Kofi, et al.. (2016). Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database. International Journal of Clinical Practice. 70(5). 380–388. 30 indexed citations
15.
Xu, Yihua, Xiaofeng Zhou, Brandon T. Suehs, et al.. (2015). A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Safety. 38(8). 749–765. 39 indexed citations
16.
Walker, Alexander M., Xiaofeng Zhou, Ashwin N. Ananthakrishnan, et al.. (2015). Computer-assisted expert case definition in electronic health records. International Journal of Medical Informatics. 86. 62–70. 24 indexed citations
17.
Zhou, Xiaofeng, et al.. (2013). An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance. Drug Safety. 36(2). 119–134. 65 indexed citations
18.
Zhou, Xiaofeng. (2004). Preface. Journal of Materials Processing Technology. 151(1-3). 1–2. 1 indexed citations
19.
Hauben, Manfred & Xiaofeng Zhou. (2003). Quantitative Methods in Pharmacovigilance. Drug Safety. 26(3). 159–186. 136 indexed citations
20.
Li, Xinghu & Xiaofeng Zhou. (2003). The properties of gasoline and effect of this properties on calculation of air-fuel ratio. SAE technical papers on CD-ROM/SAE technical paper series. 1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026